A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses...

Authors :: Adler, Stuart P.
Plotkin, Stanley A.
Gyulai, Zsofia
Cox, William I.
Gonczol, Eva
Cadoz, Michel
Meric, Claude
Jian Ben Wang
Dellamonica, Pierre
Best, A1 M.
Zahradnik, John
Pincus, Steve
Berencsi, Klara
Source :: Journal of Infectious Diseases; 9/1/99, Vol. 180 Issue 3, p843, 4p
Publication Year :: 1999
Abstract: Examines a canarypox virus (ALVAC) expressing cytomegalovirus (CMV) glycoprotein for the development of a vaccine against CMV. Drugs received by the patients under study; Ability of ALVAC-CMV to induce potentially protective levels of neutralizing antibodies.

Full Text Access

Tools